Texas Oncology

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 1, 2025	Thyme Care	$97.0M Series D	—	AlleyCorp, Alumni Ventures, Andreessen Horowitz, CVS Health, Echo Health Ventures, Oak HC/FT, Town Hall Ventures, Waverley Capital, Konstantin von Unger, Vivek Garipalli, Dan Mendelson, Andreessen Horowitz, Concord Health Partners, Foresite Capital, Frist Cressey Ventures, Humana